Latest News

  • New fragmentome technology can detect early liver fibrosis and cirrhosis
    on March 5, 2026 at 2:51 am

    Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test using genome-wide cell-free DNA (cfDNA) fragmentation patterns and repeat landscapes can detect early liver fibrosis and cirrhosis, and may also reveal signals of broader chronic disease burden.

  • New study examines blood clot risks for female astronauts in microgravity
    on March 4, 2026 at 7:07 pm

    Just a few days in simulated microgravity can subtly change the way women's blood clots, sparking bigger questions about health monitoring protocols for astronauts who can spend six months or more in orbit, say Simon Fraser University researchers.

  • 3D-printed model offers chance for surgeons to rehearse heart surgeries
    on March 4, 2026 at 5:03 pm

    Washington State University researchers have developed a 3D-printed model of the left side of the heart that contracts and beats, offering the chance for surgeons and medical students to rehearse important heart surgeries on a model that acts like the real thing.

  • Satellite livers could provide booster function for patients awaiting transplants
    on March 4, 2026 at 12:34 pm

    More than 10,000 Americans who suffer from chronic liver disease are on a waitlist for a liver transplant, but there are not enough donated organs for all of those patients.

  • FDA clears cloud-based AI system to forecast predicted delivery date
    on March 3, 2026 at 3:03 am

    Ultrasound AI, a pioneer in artificial intelligence applications for medical imaging, today announced it has received FDA De Novo clearance for its flagship Delivery Date AI technology, a cloud-based SaMD that determines a Predicted Delivery Date (PDD) solely from standard ultrasound images and seamless integration into current OB/MFM prenatal visit workflows; PDD is provided in real-time for actionable decision-making by the clinical team.